BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1490367)

  • 1. The role of bcl-2 in lymphoid differentiation and neoplastic transformation.
    Strasser A; Harris AW; Cory S
    Curr Top Microbiol Immunol; 1992; 182():299-302. PubMed ID: 1490367
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncogene cooperation and B-lymphoid tumorigenesis in Emu-myc transgenic mice.
    Alexander WS; Bernard O; Langdon WY; Harris AW; Adams JM; Cory S
    Haematol Blood Transfus; 1989; 32():423-7. PubMed ID: 2696688
    [No Abstract]   [Full Text] [Related]  

  • 3. Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells.
    Cory S; Harris AW; Strasser A
    Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):289-95. PubMed ID: 7846127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immortalization and malignant transformation of differentiated cells by oncogenes in vitro and in transgenic mice.
    Paul D; Schmidt GH
    Crit Rev Oncog; 1989; 1(3):307-21. PubMed ID: 2488135
    [No Abstract]   [Full Text] [Related]  

  • 5. Retroviral oncogenes: interrelationships between neoplastic transformation and cell differentiation.
    Auersperg N; Roskelley C
    Crit Rev Oncog; 1991; 2(2):125-60. PubMed ID: 1854833
    [No Abstract]   [Full Text] [Related]  

  • 6. Oncogene expression and regulation in normal lymphocytes and lymphocytes from patients with autoimmune diseases.
    Boumpas DT; Eleftheriades EG; Barez S; Tsokos GC
    Anticancer Res; 1988; 8(5A):977-84. PubMed ID: 3052263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18).
    McDonnell TJ; Korsmeyer SJ
    Nature; 1991 Jan; 349(6306):254-6. PubMed ID: 1987477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of retroviral and cellular transforming genes with hematopoietic cells.
    Eva A; Pierce JH; Aaronson SA
    Ann N Y Acad Sci; 1987; 511():148-70. PubMed ID: 3326463
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A; Harris AW; Bath ML; Cory S
    Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction: oncogenes and differentiation.
    Enrietto PJ; Beug H
    Semin Cancer Biol; 1994 Apr; 5(2):91-4. PubMed ID: 8061333
    [No Abstract]   [Full Text] [Related]  

  • 11. BCR/ABL enhances growth of multipotent progenitor cells but does not block their differentiation potential in vitro.
    Gishizky ML; Witte ON
    Curr Top Microbiol Immunol; 1992; 182():65-72. PubMed ID: 1490392
    [No Abstract]   [Full Text] [Related]  

  • 12. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Vaux DL; Cory S; Adams JM
    Nature; 1988 Sep; 335(6189):440-2. PubMed ID: 3262202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes.
    Amsterdam A; Selvaraj N
    Endocr Rev; 1997 Aug; 18(4):435-61. PubMed ID: 9267759
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor suppressor genes: studies with hybrid mouse cells.
    Harris H
    Immunol Ser; 1990; 51():1-13. PubMed ID: 2095915
    [No Abstract]   [Full Text] [Related]  

  • 15. The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia.
    Xu Y; Sumter TF; Bhattacharya R; Tesfaye A; Fuchs EJ; Wood LJ; Huso DL; Resar LM
    Cancer Res; 2004 May; 64(10):3371-5. PubMed ID: 15150086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
    Luke JJ; Van De Wetering CI; Knudson CM
    Cell Death Differ; 2003 Jun; 10(6):740-8. PubMed ID: 12761582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells.
    Strasser A; Harris AW; Cory S
    Oncogene; 1993 Jan; 8(1):1-9. PubMed ID: 8423986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor diversity prevents T-cell lymphoma development.
    Newrzela S; Al-Ghaili N; Heinrich T; Petkova M; Hartmann S; Rengstl B; Kumar A; Jäck HM; Gerdes S; Roeder I; Hansmann ML; von Laer D
    Leukemia; 2012 Dec; 26(12):2499-507. PubMed ID: 22643706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of a new human oncogene from a diffuse B-cell lymphoma.
    Eva A; Aaronson SA
    Nature; 1985 Jul 18-24; 316(6025):273-5. PubMed ID: 3875039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanisms of neoplastic transformation.
    Luzzatto L
    Eur J Cancer; 2001 Oct; 37 Suppl 8():S114-7. PubMed ID: 11602377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.